Bioindustrial Scale-Up for Supply Chains and Energy Resiliency Act of 2026 aims to enhance U.S. biomanufacturing capacity and energy resiliency.
The Bioindustrial Scale-Up for Supply Chains and Energy Resiliency Act of 2026 seeks to address the United States' insufficient biomanufacturing capacity and the lack of commercial-scale biomanufacturing facilities. The bill mandates the establishment of at least two bioindustrial technology maturation facilities by September 30, 2030, to conduct research, development, and demonstration of biotechnology-based products. These facilities will focus on derisking product and process technologies, and will be precommercial and available to both governmental and nongovernmental users.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.